Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study
de Abajo, Francisco J, Rodríguez-Martín, Sara, Lerma, Victoria, Mejía-Abril, Gina, Aguilar, Mónica, García-Luque, Amelia, Laredo, Leonor, Laosa, Olga, Centeno-Soto, Gustavo A, Ángeles Gálvez, Maria, Puerro, Miguel, González-Rojano, Esperanza, Pedraza, Laura, de Pablo, Itziar, Abad-Santos, Francisco, Rodríguez-Mañas, Leocadio, Gil, Miguel, Tobías, Aurelio, Rodríguez-Miguel, Antonio, Rodríguez-Puyol, Diego, Barreira-Hernandez, D, Zubiaur, P, Santos-Molina, E, Pintos-Sánchez, E, Navares-Gómez, M, Aparicio, R M, García-Rosado, V, Gutiérrez-Ortega, C, Pérez, C, Ascaso, A, Elvira, C
Published in The Lancet (30.05.2020)
Published in The Lancet (30.05.2020)
Get full text
Journal Article
Web Resource
Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: a retrospective cohort study
de Abajo, Francisco J, Rodríguez-Miguel, Antonio, Rodríguez-Martín, Sara, Lerma, Victoria, García-Lledó, Alberto
Published in BMC medicine (12.05.2021)
Published in BMC medicine (12.05.2021)
Get full text
Journal Article